Adherence to statin therapy: why aren't we doing better? (Q44264690)

1 December 2017

0 references

Adherence to statin therapy: why aren't we doing better? (English)

1 reference

1 December 2017

1 reference

Frank M Sacks

1

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

American Journal of Medicine

1 December 2017

published in

1 reference

1 December 2017

volume

113

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

685-686

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

Lipid lowering in a multidisciplinary clinic compared with primary physician management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901428-6

10.1016/S0002-9343(02)01428-6

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference